期刊文献+

心脏移植物血管病变的研究进展 被引量:2

原文传递
导出
摘要 心脏移植是目前对终末期心力衰竭患者最为有效的治疗措施,尽管心脏移植术后患者预后已经明显改善,但心脏血管移植物病变(CAV)是患者远期死亡的主要原因之一。现对CAV的发病机制、诊断及治疗的最新研究进展进行综述。一、CAV的特点及发病机制心脏移植物血管病变累及移植心脏冠状动脉全层,其病理特征为弥漫性、进展性、同心圆样的内膜增厚。
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2014年第4期923-924,共2页 Chinese Journal of Experimental Surgery
  • 相关文献

参考文献18

  • 1Stehlik J, Edwards LB, Rowe A, et al. ISHLT international registry for heart and lung transplantation-three decades of sci- entific contributions [ J ]. Transplant Rev, 2013,27(2) :38-42.
  • 2Belperio JA, Ardehali A. Chemokines and transplant vaseulopathy [J ]. Circ Res, 2008,103 ( 5 ) :454-466.
  • 3Zimmer RJ, Lee MS. Transplant coronary artery disease [ J ]. JACC Cardiovase In- terv,2010,3 (4) :367-377.
  • 4Colvin-Adams M, Agnihotfi A. Cardiac al- lograft vasculopathy: elrrent knowledge and future direction[ J]. Clin Transplant, 2011,25 (2) :175-184.
  • 5陈勇,崔大祥,孙凯,杨雁灵,戴辉.Fas介导细胞凋亡通路在慢性排斥反应所致移植物血管病变中的作用[J].中华实验外科杂志,2003,20(10):930-932. 被引量:3
  • 6韩振,夏求明.血管紧张素转换酶抑制剂对心脏移植后冠状血管增殖病变的影响[J].中华实验外科杂志,2006,23(12):1478-1480. 被引量:2
  • 7Pantou MP, Manginas A, Alivizatos PA, et al. Connective tissue growth factor ( CTGF/CCN2 ) : a protagonist in cardiae allografi vasculopathy development? [ J ]. J Heart Lung Transplant, 2012,31(8) :881-887.
  • 8Toyoda Y, Guy TS, Kashem A. Present sta- tus and future perspectives of heart trans- plantation[J]. Cire J,2013,77 (5): 1097-1110.
  • 9Mehra MR, Crespo-Leiro MG, Dipchand A, et al. International Society for Heart and Lung Transplantation working formu- lation of a standardized nomenclature or cardiac allograft vasculopathy-2010 [ J ]. J Heart Lung Transplant, 2010, 29 ( 7 ) : 717-727.
  • 10Tona F, Osto E, Tarantini G, et al. Coro- nary flow reserve by transthoracic echo- cardiography predicts epicardial intimal thickening in cardiac allografl vasculopa- thy[ J ]. Am J Transplant, 2010,10 ( 7 ) : 1668-1676.

二级参考文献22

  • 1卫洪超,何庚戌,胡盛寿,张浩,王屹,唐跃.建立一种标准化急性心肌梗死动物模型[J].中华实验外科杂志,2005,22(7):876-878. 被引量:20
  • 2马毅,陈细桃,朱晓峰,何晓顺,陈规划.大鼠异位心脏移植模型的术式探讨[J].中华实验外科杂志,2005,22(10):1238-1240. 被引量:15
  • 3Casciola-Rosen L, Rosen A, Petri M, et al. Surface blebbs on apoptotic ceils are sites of enhanced procoagulant activity: implication for coagulation events and antigenic spread in systemic lupus erythomatosus.Proc Natl Acad Sci USA, 1996, 93 : 1624-1629.
  • 4Behrendt D, Ganz P, Fang JC. Cardiac allograft vascuiopathy. Curr Opin Cardiol, 2000, 15:422-429.
  • 5Corts WG, Johnson MR. The challenge of rejection and cardiac allograft vasculopathy. Heart Fail Rev, 2001, 6:227-240.
  • 6Armstrong AT, Straueh AR, Starling RC, et al. Morphometric analysis of neointimal formation in murine cardiac allografts: II. Rate and location of lesion development. Transplantation, 1997, 64: 322-328.
  • 7Miller LW, Granville DJ, Narula J, et al. Apoptosis in cardiac transplant rejection. Cardiol Clin, 2001, 19 : 141-154.
  • 8Koglin J, Russell ME. Alloimmune-mediated apoptosis: comparison in mouse models of acute and chronic cardiac rejection. Transplantation,1999, 67: 904-909.
  • 9Josien R, Muschen M, Gilbert E, et al, Fas ligand, tumor necrosis factor-alpha expression, and apoptosis during allograft rejection and tolerance. Transplantation, 1998, 66 : 887-893.
  • 10Sara M, Suhara T, Walsh K. Vascular endothelial cells and smooth muscle cells differ in expression of Fas and Fas ligand and in sensitivity to Fas ligand-induced cell death: implications for vascular disease and therapy. Arterioscler Thromb Vasc Biol, 2000, 20:309-316.

共引文献10

同被引文献19

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部